drugset / Trial / NCT05661942

Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

NCT05661942

Phase 4 Completed 92 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to see how well calcium pre-treatment works for decreasing incidence of drug-induced hypotension after diltiazem administration for treatment of atrial flutter with rapid ventricular rate.

Timeline

Start
2022-11-30
Primary completion
2024-11-20
Completion
2024-11-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator calcium gluconate Small molecule 1 g Intravenous